Market News
Stay updated with the latest market trends, earnings, and economic indicators.

Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy today - 16 June 2026
Shares to buy or sell: Chandan Taparia has recommended three stocks to buy today, 16 June 2026 - Bharat Forge, BSE and The Phoenix Mills shares.
Tata Motors among 4 stocks showing bullish RSI upswing
Four Nifty 500 stocks that gained more than 8% were identified through StockEdge.com's RSI Trending Up scan on June 12. The stocks showed RSI values crossing above 50 from lower levels, indicating strengthening momentum. The list includes Tata Motors, Tata Teleservices (Maharashtra), Netweb Technologies India and Authum Investment & Infrastructure.
Analyst suggests buying Nestle India, Bharat Forge today: Check targets
Stocks to buy: Ruchit Jain of Motilal Oswal Financial Services has recommended buying the shares of Nestle India, and Bharat Forge today

Nifty 500 Q4 Review: HDFC Bank, Indian Oil, Tata Motors Among Top Winners, Losers; Key Sector Trend — Read Motilal Oswal's Report
Of the 23 key sectors, 14 posted double-digit profit growth in Q4 FY26.
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.

Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.

Motilal Oswal 'bull case' sees 71% upside in this auto parts manufacturer
Motilal Oswal said Gabriel India is undergoing a structural transformation from a single-product suspension manufacturer into a diversified mobility platform, opening up a significantly larger growth runway, and it believes it is increasingly being positioned as the primary growth vehicle of the Anand Group.
Gabriel India shares rise 4%; Motilal Oswal initiates coverage with 'Buy'
Motilal Oswal Financial Services initiated coverage on the stock with a 'Buy' rating and a target price of ₹1,266

Gabriel India Shares in Focus After Motilal Oswal Initiates Coverage with 'Buy' — Check Target Price, Potential Upside
Consistent dividend payouts reflects Gabriel India's ability to generate and return surplus cash to shareholders across business cycles.

Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends 3 stocks to buy today amid RBI policy - 5 June 2026
Shares to buy or sell: Chandan Taparia has recommended three stocks to buy today, 5 June 2026 - BSE, Laurus Labs and Exide Industries shares.

Ola Electric QIP Fetches Rs 780 Crore As EV Maker's Issue Gets 56% Oversubscription
Mirae Asset received the highest allocation of 15.38% through multiple allocations followed by Motilal Oswal which received 9.61%.